# OnCo record bdc-4182 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bdc-4182/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "bdc-4182" ;
  schema:name "BDC-4182"@en ;
  schema:description "BDC-4182 is an experimental monoclonal antibody from Bolt Biotherapeutics in phase 2 trials for gastric & gastro-oesophageal junction cancer, aimed at Claudin 18.2."@en ;
  schema:url <https://onco.cc/drugs/bdc-4182/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=BDC-4182>, <https://boltbio.com/pipeline/> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:targets <https://onco.cc/targets/cldn18-2/> ;
  onco:companies <https://onco.cc/companies/bolt-biotherapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06921837/> .